1[1]Goldman B.Multidrug resistance:can new drugs help chemotherapy score against cancer?[J].J Natl Cancer Inst,2003,95(4):255
2[2]Mattern J.Drug resistance in cancer:a multifactorial problem[J].Anticancer Res,2003,23(2C):1769
3[3]Bush JA,Li G.Cancer chemoresistance:the relationship between p53 and multidrug transporters[J].Int J Cancer,2002,98(3):323
4[4]Tsuruo T,Naito M,Tomida A,et al.Molecular targeting therapy of cancer:drug resistance,apoptosis and survival signal[J].Cancer Sci,2003,94(1):15
5[5]Varma MV,Ashokraj Y,Dey CS,et al.P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement[J].Pharmacol Res,2003,48(4):347
6[6]Thomas H,Coley HM.Overcoming multidrug resistance in cancer:an update on the clinical strategy of inhibiting p-glycoprotein[J].Cancer Control,2003,10(2):159
7[7]Juliano RL,Ling V.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants[J].Biochim Biophys Acta,1976,455(1):152
8[8]Sharma R,Awasthi YC,Yang Y,et al.Energy dependent transport of xenobiotics and its relevance to multidrug resistance[J].Curr Cancer Drug Targets,2003,3(2):89
9[9]Sparreboom A,Danesi R,Ando Y,et al.Pharmacogenomics of ABC transporters and its role in cancer chemotherapy[J].Drug Resist Update,2003,6(2):71
